In the past six months,
Clorox Company (CLX) stock experienced a
12% drop, with its Q1 results leading to an adjustment in its price target. Reports indicate the investors continue to face losses, with a further 7.8% dip this week due to a decline in earnings. The company declared a regular quarterly dividend of $1.22 per share, indicating their
steady commitment to dividends. Conversely, its CFO, Kevin Jacobsen, is set to retire with Luc Bellet replacing him. Recent statements from Jim Cramer highlighted weaknesses in their earnings leading to downward pressure on the stock. However, the company's
defensive appeal and regular dividends still make it suitable for certain investors. Clorox has been noted for its resilience amidst cost pressures and has been making
strategic moves in response to market volatility. It has recently completed the divestiture of its Better Health VMS business and has partnered with M2030 for supply chain climate action. However, as cautionary outlook clouds its Q2 beat, the stock continues to face challenges. The company also looks to boost its ESG bona fides through advancing ingredient and product safety.
Clorox Company CLX News Analytics from Thu, 01 Aug 2024 07:00:00 GMT to Fri, 11 Apr 2025 15:53:24 GMT -
Rating 0
- Innovation -4
- Information 6
- Rumor 0
